http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105770220-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c67769e5ddce1cd1495c4bd3fd381eaa |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
filingDate | 2016-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e8c666f583fde28518d7d4dd525d03d |
publicationDate | 2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105770220-A |
titleOfInvention | Pharmaceutical composition containing losartan and capable of treating hypertension and preparation method thereof |
abstract | The invention belongs to the technical field of medicine and particularly relates to a pharmaceutical composition containing losartan and capable of treating hypertension and a preparation method thereof. The pharmaceutical composition containing losartan and capable of treating hypertension is prepared from the following active pharmaceutical ingredients in parts by weight: 40-60 parts of losartan, 2000-4000 parts of urtica macrorrhiza, 2000-4000 parts of herba wedeliae, 2000-4000 parts of grape vine and leaves and 2000-4000 parts of typha root. According to the pharmaceutical composition, traditional Chinese medicines are combined with the losartan, so that common adverse reactions of the losartan can be avoided, and the treatment effect on hypertension is improved. |
priorityDate | 2016-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.